Calidi Biotherapeutics (CLDI) Current Assets (2021 - 2025)

Calidi Biotherapeutics has reported Current Assets for 5 years, with the latest figure at $6.3 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 38.83% year-over-year to $6.3 million; the trailing twelve-month figure through Dec 2025 stood at $6.3 million (down 38.83% YoY), and the FY2025 full-year result was $6.3 million, down 38.83% from the prior year.
• Current Assets for Q4 2025 stood at $6.3 million, down from $11.0 million in the prior quarter.
• The five-year high for Current Assets was $11.7 million in Q3 2023, with the low at $268864.0 in Q1 2023.
• Average Current Assets over 5 years is $4.3 million, with a median of $1.9 million recorded in 2024.
• Year-over-year, Current Assets jumped 2339.4% in 2023 and sank 81.0% in 2024.
• Tracing CLDI's Current Assets over 5 years: stood at $1.5 million in 2021, then tumbled by 47.02% to $786000.0 in 2022, then surged by 447.46% to $4.3 million in 2023, then soared by 137.67% to $10.2 million in 2024, then slumped by 38.83% to $6.3 million in 2025.
• The last three Current Assets figures came in at $6.3 million (Q4 2025), $11.0 million (Q3 2025), and $6.0 million (Q2 2025), per Business Quant data.

Peer Comparison